Audentes Therapeutics, Inc. (BOLD)
25.86  0.03 (0.12%)  11-15 16:11
Open: 26.1
High: 26.37
Low: 25.65
Volume: 296,400
Ask: x
Bid: x
Market Cap: 1,184M
PE Ratio: -6.49
Exchange: NASDAQ Global Market
Industry: Biotechnology
Sector: Healthcare
Technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell buy
Resistance 2: 30.00
Resistance 1: 28.34
Pivot price: 27.30
Support 1: 25.65
Support 2: 21.34
52w High: 41.65
52w Low: 17.95
MSFT149.971.91 (1.29%)
TWTR29.250.36 (1.25%)
BAC32.930.23 (0.7%)
AMZN1739.49-15.11 (-0.86%)
FB195.11.95 (1.01%)
GM0 (0%)

Audentes Therapeutics Inc is a biotechnology company. It is engaged in developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects.

Zoom in Zoom out
Draw lines
Horizontal lines
Parallel lines
Fibonacci lines
Remove studies
Shot and share
EPS -3.990
Book Value 8.420
PEG Ratio -0.48
Gross Profit 0.000
Profit Margin (%) 0.00
Operating Margin (%) 0.00
Return on Assets (ttm) -29.9
Return on Equity (ttm) -50.6
Share on Facebook Tweet this page Share on google plus

Foxchart international: United States Canada United Kingdom Australia New Zealand Singapore India

© All Rights Reserved. | United States NYSE NASDAQ AMEX stock markets, stock quotes and stock technical analysis charts. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX